BCM
CELU icon

BlueCrest Capital Management’s Celularity CELU Stock Holding History

BlueCrest Capital Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-174,273
Closed -$17.6M – 508
2021
Q1 		$17.6M Buy
174,273
+42,606
+32% +$4.37M 0.29% 61
2020
Q4 		$14.5M Buy
+131,667
New +$14M 0.32% 78
2019
Q4 		– Sell
-50,000
Closed -$4.97M – 419
2019
Q3 		$4.97M Buy
+50,000
New +$4.91M 0.34% 68

Other funds holding CELU

WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

BlueCrest Capital Management's CELU Position: Q2 2021 in Review

BlueCrest Capital Management sold out of Celularity (CELU) in Q2 2021, closing a stake of 174,273 shares — an estimated $17.6M sold.

BlueCrest Capital Management first reported a position in CELU in Q3 2019 and held it in 3 quarters. The position peaked at $17.6M in Q1 2021. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

  • BlueCrest Capital Management reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
  • BlueCrest Capital Management sold 174,273 Celularity shares in Q2 2021, an estimated $17.6M.
  • BlueCrest Capital Management first reported a position in Celularity in Q3 2019 and held it in 3 quarters.
  • BlueCrest Capital Management's Celularity position peaked at $17.6M in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on BlueCrest Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.